_:vb50946383	<http://www.w3.org/2002/07/owl#annotatedSource>	<http://purl.obolibrary.org/obo/DOID_0112256> .
_:vb50946383	<http://www.geneontology.org/formats/oboInOwl#hasDbXref>	"url:https://pubmed.ncbi.nlm.nih.gov/3384945/"^^<http://www.w3.org/2001/XMLSchema#string> .
_:vb50946383	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/2002/07/owl#Axiom> .
_:vb50946383	<http://www.w3.org/2002/07/owl#annotatedProperty>	<http://purl.obolibrary.org/obo/IAO_0000115> .
_:vb50946383	<http://www.w3.org/2007/05/powder-s#describedby>	<https://demo.openlinksw.com/about/id/entity/http/purl.obolibrary.org/obo/doid.owl> .
_:vb50946383	<http://purl.org/dc/elements/1.1/type>	<http://purl.obolibrary.org/obo/ECO_0007645> .
_:vb50946383	<http://www.w3.org/2002/07/owl#annotatedTarget>	"An amino acid metabolic disorder characterized by failure of cells to incorporate methyltetrahydrofolate into methionine, impaired methionine synthase activity in the presence of a reducing agent, and somewhat variable features that include delayed psychomotor development, hypotonia, megaloblastic anemia, homocystinuria, and hypomethioninemia that has_material_basis_in homozygous or compound heterozygous mutation in MTR on chromosome 1q43."^^<http://www.w3.org/2001/XMLSchema#string> .
_:vb50946383	<http://www.geneontology.org/formats/oboInOwl#hasDbXref>	"url:https://pubmed.ncbi.nlm.nih.gov/8968737/"^^<http://www.w3.org/2001/XMLSchema#string> .